Current Valuation
N/A
As of March 31, 2025
Total Funding Raised
$5.6M
Last Round
Later Stage VC

$300.0K

Last Funding
Mar 2025

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

QSM Diagnostics is currently valued at N/A as of March 31, 2025. The company has raised a total of $5.6M in funding.

Investment Perspective

QSM Diagnostics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track QSM Diagnostics Valuation Updates

Get notified when QSM Diagnostics raises new funding or valuation changes

What is QSM Diagnostics Worth in 2025?

As of 2025, QSM Diagnostics is valued at N/A, based on the company's Later Stage VC funding round in March 31, 2025. This valuation positions QSM Diagnostics as one of the leading private companies in the sector.

QSM Diagnostics Valuation History

QSM Diagnostics's funding history demonstrates steady growth and investor confidence.

How QSM Diagnostics Valuation is Determined

Private company valuations like QSM Diagnostics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

QSM Diagnostics Valuation FAQs

Is QSM Diagnostics profitable?

QSM Diagnostics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does QSM Diagnostics's valuation compare to competitors?

QSM Diagnostics is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will QSM Diagnostics IPO?

QSM Diagnostics has not announced plans for an initial public offering. Until an IPO, investors can access QSM Diagnostics shares through secondary market platforms.